Standard Imaging announces new Adaptivo dosimetry software officially released with CE Mark

Standard Imaging, Inc., a global leader in quality assurance for cancer treatment, announced the official release of their new AdaptivoTM software with CE Marking for sale in Europe. Hailed as the future of patient dosimetry, Adaptivo is the first - and only - software that provides a true picture of the patient and dose at each stage of radiation therapy treatment. 

Adaptivo was first announced in late 2015 with FDA 510k clearance for sale in the United States and garnered considerable attention. The first of its kind, Adaptivo tracks the dosimetric effect of changes in patient anatomy and position on the treatment plan - giving Medical Physicists the information they need to provide the best care possible. The latest iteration of the software, which has just been released, promises to be even better.